Effects of propafenone on K currents in human atrial myocytes

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1153-1162

  Seki, Akiko ^a   Hagiwara, Nobuhisa ^a   Kasanuki, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti arrhythmic drugs; Human atrial cells; K+ channels; Propafenone; Whole cell voltage clamp method

Indexed keywords

ANTIARRHYTHMIC AGENT; PROPAFENONE;

ADOLESCENT; ADULT; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART ATRIUM MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; POTASSIUM CURRENT; PRIORITY JOURNAL; VOLTAGE CLAMP;

EID: 0033046678     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702428     Document Type: Article

References (41)

1. ALIOT, E. & DENJOY, I. (1996). Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The flecainide af French study group. Am. J. Cardiol., 77, 66A-71A.
2. ANTMANN, E.M., BEAMER, A.D., CANTILLON, C., MCGOWAN, N., GOLDMAN, L. & FRIEDMAN, P.L. (1988). Long-term propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter. J. Am. Coll. Cardiol., 12, 1005-1011.
3. BOTTO, G.L., BONINI, W., BROFFONI, T., CAPPELLETTI, G., FALCONE, C., LOMBARDI, R., PAULESU, A., PEDRAGLIO, E. & FERRARI, G. (1994). Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm. Pacing & Clin. Electrophysiol., 17, 2114-2117.
4. CAPUCCI, A., BORIANI, G., BOTTO, G.L., LENZI, T., RUBINO, I., FALCONE, C., TRISOLINO, G., DELLA CASA, S., BINETTI, N., CAVAZZA, M., SANGUINETTI, M. & MAGNANI, B. (1994). Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am. J. Cardiol., 74, 503-505.
5. CHIMIENTI, M., CULLEN, M.T. & CASADEI, G. (1996). Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the flecainide and propafenone Italian study investigators. Am. J. Cardiol., 77, 60A-75A.
6. COBBE, S.M. & RAE, A.P. (UK Propafenone PSVT Study Group, 1995). A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation, 92, 2550-2557.
7. CRIJNS, H.J.G.M., GROSSELINK, A.T.M. & LIE, K.I. (1996). Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. Cardiovasc. Drugs and Ther., 10, 145-152.
8. DELPO'N, E., VALENZUELA, C., GAY, P., FRANQUEZA, L., SNYDERS, D.J. & TAMARGO, J. (1997). Block of human cardiac Kv 1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels. Cardiovasc. Research, 35, 341-350.
9. DUAN, D., FERMINI, B. & NATTEL, S. (1992). Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J. Pharmacol. Exp. Ther., 264, 1113-1123.
10. DUKES, I.D., CLEEMANN, L. & MORAD, M. (1990). Tedisamil blocks the transient and delayed rectifier K currents in mammalian cardiac and glial cells. J. Pharmacol. Exp. Ther., 254, 560-569.
11. ESCANDE, D., COULOMBE, A., FAIVRE, J.-F., DEROUBAIX, E. & CORABOEUF, E. (1987). Two types of transient outward currents in adult human atrial cells. Am. J. Physiol., 252, H142-H148.
12. FERMINI, B., WANG, Z., DUAN, D. & NATTEL, S. (1992). Differences in rate dependence of transient outward current in rabbit and human atrium. Am. J. Physiol., 263, H1747-H1754.
13. GILLIS, A.M. & KATES, R.E. (1986). Influence of protein binding on the myocardial uptake and pharmacodynamics of propafenone. J. Cardiovasc. Pharmacol., 8, 1163-1167.
14. HAGIWARA, N., IRISAWA, H., KASANUKI, H. & HOSODA, S. (1992a). Background current in the sino-atrial node cells of the rabbit heart. J. Physiol., 448, 53-72.
15. HAGIWARA, N., MATSUDA, N., SHODA, M. & IRISAWA, H. (1992b). Stretch-activated anion currents of rabbit cardiac myocytes. J. Physiol., 456, 285-302.
16. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers. Arch., 391, 85-100.
17. HARRISON, D.C. (1985). Antiarrhythmic drug classification: new science and practical applications. Am. J. Cardiol., 56, 185-187.
18. ISENBERG, G. & KLÖCKNER, U. (1982). Calcium tolerant ventricular myocytes prepared by preincubation in a 'KB-medium'. Pflügers. Arch., 395, 6-18.
19. KAJIMOTO, K., HAGIWARA, N., KASANUKI, H. & HOSODA, S. (1997). Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes. Br. J. Pharmacol., 121, 1549-1556.
20. KIRCHHOF, C., WIJFFELS, M., BRUGADA, J., PLANELLAS, J. & ALLESSIE, M. (1991). Mode of action of a new class Ic drug (ORG 7797) against atrial fibrillation in conscious dogs. J. Cardiovasc. Pharmacol., 17, 116-124.
21. KOSMALA, W., KUCHARSKI, W., HACZYNSKI, J., KOBUSIAK-PROKOPOWICZ, M. (1994). Propafenone, flecainide, procainamide in the treatment of a fresh attack of atrial fibrillation. Wiadomosci Lekarskie, 47 (21-24), 801-807.
22. 2+ current by mechanical stimulation in single rabbit cardiac myocytes. Circ. Res., 78, 650-659.
23. PORTERFIELD, J.G. & PORTERFIELD, L.M. (1988). Therapeutic efficacy and safety of oral propafenone for atrial fibrillation. Am. J. Cardiol., 63, 114-116.
24. PRITCHETT, E.L.C., MCCARTHY, E.A. & WILKINSON, W.E. (1991). Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. Ann. Int. Med., 114, 539-543.
25. REIMOLD, S.C., CANTILLON, C.O., FRIEDMAN, P.L. & ANTMAN, E.M. (1993). Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am. J. Cardiol., 71, 558-563.
26. RENSMA, P.L., ALLESSIE, M.A., LAMMERS, W.J.E.P., BONKE, F.I.M. & SCALIJ, M.J. (1988). Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ. Res., 62, 395-410.
27. SAKAI, R., HAGIWARA, N., KASANUKI, H. & HOSODA, S. (1995). Chloride conductance in human atrial cells. J. Mol. Cell. Cardiol., 27, 2403-2408.
28. SAKAI, R., HAGIWARA, N., MATSUDA, N., KASANUKI, H. & HOSODA, S. (1996). Sodium-potassium pump current in rabbit sino-atrial node cells. J. Physiol (Lond)., 490, 51-62.
29. SHODA, M., HAGIWARA, N., KASANUKI, H. & HOSODA, S. (1997). ATP-activated cationic current in rabbit sino-atrial node cells. J. Mol. Cell. Cardiol., 29, 689-695.
30. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J. Pharmacol. Exp. Ther., 269, 66-74.
31. SNYDERS, D.J., KNOTH, K.M., ROBERDS, S.L. & TAMKUN, M.M. (1991). Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac channel. Molecular Pharmacology, 41, 322-330.
32. SNYDERS, D.J., TAMKUN, M.M. & BENNETT, P.B. (1993). A rapidly activating slowly inactivating potassium channel cloned from human heart. J. Gen. Physiol., 101, 513-543.
33. STROOBANDT, R., STIELS, B. & HOEBRECHTSA, R. (1997). Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone atrial fibrillation trial investigators. Am. J. Cardiol., 79, 418-423.
34. SUTTORP, M.J., KINGMA, J.H., JESSURUN, E.R., LIE-A-HUEN, L., VAN HEMEL, N.M. & LIE, K.I. (1990). The value of class Ic antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J. Am. Coll. Cardiol., 16, 1722-1727.
35. WANG, J., BOURNE, G.W., WANG, Z., VILLEMAIRE, C., TALAJIC, M. & NATTEL, S. (1993a). Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Circulation, 88, 1030-1044.
36. WANG, Z., FERMINI, B. & NATTEL, S. (1993b). Sustained depolarization-induced outward current in human atrial myocytes. Circ. Res., 73, 1061-1076.
37. WANG, Z., FERMINI, B. & NATTEL, S. (1995). Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J. Pharmacol. Exp. Ther., 272, 184-196.
38. WANG, Z., PAGE, P. & NATTEL, S. (1992). Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ. Res., 71, 271-287.
39. WANG, Z., PELLETIER, L.C., TALAJIC, M. & NATTEL, S. (1990). Effects of flecainide and quinidine on human atrial action potentials. Circulation, 82, 274-283.
40. WEINER, P., GANAM, R., GANEM, R., ZIDAN, F. & RABNER, M. (1994). Clinical course of recent-onset atrial fibrillation treated with oral propafenone. Chest, 105, 1013-1016.
41. YUE, L., FENG, J., GASPO, R., LI, G.-R., WANG, Z. & NATTEL, S. (1997). Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res., 81, 512-525.